by Richard Daverman, PhD
December 4, 2013 -- Zhejiang Hisun Pharma will raise at least 2 billion RMB ($328 million) in a private placement. The company will offer up to 139.5 million new shares at a price not lower than 14.26 RMB per share (the shares are currently trading at 17.22 RMB). Hisun will use the money to build facilities for three projects: facilities for solid preparations and injections, solid preparation cancer treatments and the Phase II of its biopharmaceutical initiative. More details....
Stock Symbol: (SHA: 600267)
Help employers find you! Check out all the jobs and post your resume.
